Guillain Barre Syndrome – Annexon ANX005-GBS-05

Participate in a New Guillain‑Barré Syndrome Study

Profound Research is enrolling a Guillain-Barre Syndrome (GBS) study that is assessing an investigational medication to see how the drug interacts with the body and if it is effective.

To be eligible to participate, you must:

• Be 18-85 years of age
• Have a diagnosis of GBS
• Have GBS-related weakness no more than 10 days prior to start of study

Additional criteria apply.

Qualified participants will receive:

• Study-related care and study medication at no cost
• Financial compensation for time and travel expenses

Call us at 619-489-5613 or complete the form and our team will reach out soon to help determine your eligibility.